Journal of Translational Internal Medicine

The Journal of Translational Internal Medicine is a peer-reviewed open-access journal covering translational medicine and internal medicine worldwide, launched in December 2013 and published by De Gruyter Brill, with a 2025 Journal Impact Factor of 12.5（Journal of Translational Internal Medicine）是覆盖全球转化医学与内科学的同行评审开放获取期刊，2013 年 12 月创刊，由（De Gruyter Brill）出版，2025 年影响因子为 12.5。

Scope

• It is devoted to promoting science and practice in translational medicine and internal medicine worldwide该刊致力于推动全球转化医学与内科学的科学与实践。
• It focuses on information derived from human disease-related experimentation so as to optimize communication between basic research and clinical science该刊聚焦源自人类疾病相关实验的信息，以优化基础研究与临床科学之间的沟通。^[1]
• It has a cycling nature that runs from basic research to clinical practice and then back to basic research该刊具有从基础研究到临床实践、再由临床实践回到基础研究的循环属性。
• It publishes original articles, rapid communications, editorials, reviews, highlights and perspectives该刊发表原创论文、快速通讯、社论、综述、亮点与观点类文章。
• It covers mechanism-related disease studies and non-surgical diagnosis and treatment research, alongside advanced experience and scholarly question-and-answer pieces该刊涵盖机制相关疾病研究与非手术诊断治疗研究，并收录先进经验与学者问答类内容。^[2][3]
• With a disease-centered approach and a focus on multidisciplinary collaboration, it supports health care delivery and policy-making该刊以疾病为中心并注重多学科协作，服务于医疗保健服务提供与政策制定。

History

• It was launched in December 2013该刊于 2013 年 12 月创刊。
• It is published by the German house De Gruyter together with the Hong Kong publisher Scholar Media Publishing该刊由德国（De Gruyter）与香港出版方（Scholar Media Publishing）联合出版。
• It is academically supported by Shenyang Medical College, where the journal is based该刊由（Shenyang Medical College）提供学术支持，编辑部亦设于该校。
• It is academically supported by the International Society of Translational Sciences and several Chinese medical societies该刊由（International Society of Translational Sciences）及若干中国医学学会提供学术支持。
• Its scope spans translational medicine and internal medicine, including mechanism-related and non-surgical clinical research其范围横跨转化医学与内科学，涵盖机制相关与内科非手术临床研究。
• It is indexed in the Science Citation Index Expanded and Scopus该刊被（Science Citation Index Expanded）与（Scopus）收录。
• Its Journal Impact Factor rose from 7.4 in 2024 to 12.5 in 2025其影响因子从 2024 年的 7.4 上升至 2025 年的 12.5。

Editors

• Its editor-in-chief is Xiaojun Huang of the Peking University Institute of Hematology in Beijing其主编为北京（Peking University Institute of Hematology）的（Xiaojun Huang）。
• Its honorary editors-in-chief are Jian Kang of the First Affiliated Hospital of China Medical University in Shenyang and Patrick M. Honore of CHU Brugmann University Hospital in Brussels其名誉主编为（First Affiliated Hospital of China Medical University）的（Jian Kang）与（CHU Brugmann University Hospital, Brussels）的（Patrick M. Honore）。
• Its editorial board members include Angela Sciacqua of the University Magna Graecia of Catanzaro, Arnab Pain of King Abdullah University of Science and Technology and Ben Lv of Central South University其编委包括（University Magna Graecia of Catanzaro）的（Angela Sciacqua）、（King Abdullah University of Science and Technology）的（Arnab Pain）与（Central South University）的（Ben Lv）。
• Its editorial office is based at Shenyang Medical College in China其编辑部设在中国（Shenyang Medical College）。
• Its editorial board is international, drawing on scholars from Italy, Belgium, Saudi Arabia and China其编委具有国际性，汇聚来自意大利、比利时、沙特阿拉伯与中国的学者。